OCT 10, 2026 · JOURNAL ARTICLE
Prognostic factors affecting survival in early-stage HER2-positive breast cancer treated with adjuvant therapy
Pamukkale Medical Journal
AbstractPurpose: This study aimed to identify the prognostic and predictive factors affecting survival in patients with early-stage human epidermal growth factor receptor 2 (HER2)